Literature DB >> 6455225

Diminished suppressor cell function in patients with asbestosis.

H R Gaumer, N J Doll, J Kaimal, M Schuyler, J E Salvaggio.   

Abstract

Epidemiological and immunological studies of asbestos workers documented abnormalities in humoral and cell-mediated immunity which could result from defective immunoregulation. This study tests this hypothesis with comparison of lymphocyte function in age-, sex- and smoking-matched subjects with asbestosis. In vivo measure of delayed hypersensitivity (i.e. skin test response) was significantly depressed to two recall antigens, SKSD and Candida, in asbestosis patients. Skin reaction to dinitrochlorobenzene (DNCB) was not depressed, although lymphocytes of patients giving positive skin test reactions demonstrated a significantly lower (P less than 0.001) proliferative response to dinitrobenzene sulphonic acid (DNBSO3) in vitro. T cell counts (E-rosettes) were normal in patients with asbestosis, although a subset of T cells, those forming sheep erythrocyte rosettes after prolonged incubation (Elate), were significantly depressed (P less than 0.003). This population has been equated with 'suppressor' cells (Grossi et al., 1978). Numbers of B cells were increased nearly two-fold over controls. Mitogen response of lymphocytes was normal except at suboptimal doses of mitogens where the response is known to be influenced by suppressor cell activity, which was significantly elevated. Suppressor cell function, as determined by stimulation of peripheral blood lymphocytes preincubated with concanavalin A, was also significantly decreased in asbestosis patients (P less than 0.01).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6455225      PMCID: PMC1537209     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Rheumatoid lung changes associated with asbestosis.

Authors:  A G RICKARDS; G M BARRETT
Journal:  Thorax       Date:  1958-09       Impact factor: 9.139

2.  Autoantibodies and serum immunoglobulin levels in asbestos workers.

Authors:  A Lange; R Smolik; W Zatoński; J Szymańska
Journal:  Int Arch Arbeitsmed       Date:  1974-01-31

3.  Circulating rheumatoid and antinuclear factors in asbestos workers.

Authors:  M Turner-Warwick; W R Parkes
Journal:  Br Med J       Date:  1970-08-29

4.  Collagen biosynthesis in rat lungs during exposure to asbestos.

Authors:  H V Davis; A L Reeves
Journal:  Am Ind Hyg Assoc J       Date:  1971-09

5.  Rheumatoid factor in serum of individuals exposed to asbestos.

Authors:  B Pernis; E C Vigliani; I J Selikoff
Journal:  Ann N Y Acad Sci       Date:  1965-12-31       Impact factor: 5.691

6.  A method for dinitrochlorobenzene contact sensitization. A clinicopathological study.

Authors:  W J Catalona; P T Taylor; A S Rabson; P B Chretien
Journal:  N Engl J Med       Date:  1972-02-24       Impact factor: 91.245

7.  Asbestosis and neoplastic disorders of the hematopoietic system.

Authors:  M A Gerber
Journal:  Am J Clin Pathol       Date:  1970-02       Impact factor: 2.493

8.  The human rosette-forming cell as a marker of a population of thymus-derived cells.

Authors:  J Wybran; M C Carr; H H Fudenberg
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

9.  Tolerance and contact sensitivity to DNFB in mice. II. Specific in vitro stimulation with a hapten, 2,4-dinitrobenzene sulfonic acid (DNB-SO3Na).

Authors:  P Phanuphak; J W Moorhead; H N Claman
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

10.  Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

Authors:  L Shou; S A Schwartz; R A Good
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Immunotoxicology.

Authors:  K Miller
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

2.  Immunological consequences of asbestos exposure.

Authors:  D P Hartmann
Journal:  Surv Immunol Res       Date:  1985

Review 3.  Selected new developments in asbestos immunotoxicity.

Authors:  G J Rosenthal; E Corsini; P Simeonova
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

4.  Asbestos fibres inhibit the in vitro activity of lymphokine-activated killer (LAK) cells from healthy individuals and patients with malignant mesothelioma.

Authors:  L S Manning; M R Davis; B W Robinson
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

5.  Enhanced interleukin activity following asbestos inhalation.

Authors:  D P Hartmann; M M Georgian; Y Oghiso; E Kagan
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

6.  Asbestos exposure correlates with alterations in circulating T cell subsets.

Authors:  L G Miller; D Sparrow; L C Ginns
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

7.  A murine model of asbestosis.

Authors:  B E Bozelka; P Sestini; H R Gaumer; Y Hammad; C J Heather; J E Salvaggio
Journal:  Am J Pathol       Date:  1983-09       Impact factor: 4.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.